Julia Foldi

20PUBLICATIONS
73CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosisMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Jun 22, 2026
Personalized whole-genome-based ctDNA dynamics during neoadjuvant therapy across breast cancer subtypes: results from MONITOR-Breast.

|Mar 19, 2026
Use of ctDNA in Older Women with ER+ Breast Cancer to Facilitate Surgical De-escalation: A Prospective, Hybrid-Decentralized Trial with Correlative Studies.

Neil Carleton, Alexander C Chang, Fangyuan Chen

|Feb 26, 2026
Magee Equation 3 demonstrates predictive and prognostic value for neoadjuvant chemotherapy outcomes in estrogen receptor-positive, human epidermal growth factor receptor 2-negative breast cancer.

Jacob A Jerome, Rachel Vanderschelden, Beth Z Clark

|Nov 14, 2025
Mixed Molecular Subtypes Coexist in Estrogen Receptor Heterogeneous Primary Breast Cancers.

Julia Foldi, Kaitlyn Xiong, Matthew Liu

|Jun 11, 2025
Patterns of adjuvant bone modifying agent use in patients with early-stage breast cancer in the United States.

Nicole Odzer, Rachel Jaber Chehayeb, Sarah E Schellhorn

|May 05, 2025
Personalized Circulating Tumor DNA Testing for Detection of Progression and Treatment Response Monitoring in Patients With Metastatic Invasive Lobular Carcinoma of the Breast.

Julia Foldi, Steffi Oesterreich, Antony Tin

Pageof 4

Frequent Collaborators

8 joint publications

Lajos Pusztai

7 joint publications

Adrian V Lee

6 joint publications

Michal Marczyk

6 joint publications

Steffi Oesterreich